NCT00270348View on ClinicalTrials.gov

Effects of Ciclesonide MDI 50mg/Day and 200mg/Day (Ex-Valve) Once-Daily on Growth in Children With Mild Persistent Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

December 31, 2000

Study Completion Date

September 30, 2004

Conditions
Asthma
Interventions
DRUG

ciclesonide

Sponsors

Lead Sponsor

Sanofi

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Sanofi

INDUSTRY